Tin(IV)-based Anticancer Drugs

  • ChemPubSoc Europe Logo
  • Author: Scott Williams
  • Published Date: 04 January 2013
  • Source / Publisher: ChemMedChem/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
thumbnail image: Tin(IV)-based Anticancer Drugs

Related Societies

Organometallic compounds are widely used in catalytic chemistry, but in terms of their use in drug design, they remain a curiosity. Over the last few years medicinal chemistry research into organometallics has increased significantly, and many reported results indicate a considerable potential for these metal complexes in drug development.


The potent cytotoxic effects of tin organometallic compounds are well known and make them well suited as potential anticancer drug candidates. However, knowledge regarding their mode of action is limited.

A multidisciplinary and international group of research teams coordinated by Ingo Ott, Technische Universität Braunschweig, Germany, has provided evidence that the inhibition of thioredoxin reductase is a contributing factor in the biological effects of tin-based complexes. Virtual screening for thioredoxin reductase inhibitors had indicated this mechanism, which was further confirmed by a combination of synthetic, analytical, and biological chemistry experiments.

These results by Ott and colleagues contribute to a better understanding of the biochemistry of tin organometallics and provide new options for the rational design of improved derivatives.


Article Views: 2454

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

1 Comments

zainab allhassy wrote:

anticancer

chemical effect

Fri Jan 11 22:39:32 UTC 2013

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH